Treosulfan — Drug Intelligence | 13 EU Trials

Filter these 13 trials by condition, phase, country and more.

Open in Search →

13 Registered trials

9 Recruiting

1 Completed trials

13 Sponsors

15 Countries

Phase III

Phase II/III

Phase II

Phase III: 3 Phase II/III: 2 Phase II: 5 Phase I/II: 1 Phase IV: 1 Phase I (FiH): 1

Indications tested

Myelodysplastic syndrome 4 Ewing's sarcoma 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 2 Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia 1 Fondazione Gimema Franco Mandelli Onlus 1 Fondazione Santobono Pausilipon Onlus 1 Fondazione Telethon Ets 1 GPOH gGmbH 1 Heinrich-Heine-Universitaet Duesseldorf 1 Medizinische Hochschule Hannover 1 Ospedale Pediatrico Bambino Gesu 1 San Raffaele Hospital 1 St. Anna Childrens Cancer Research Institute GmbH 1 Technische Universitat Dresden 1

All trials

13 total

Phase II Prospective Multicenter Study of High-Dose Treosulfan/Melphalan as Consolidation Treatment in Newly Diagnosed High-Risk and Very Hi… Pending

2024-518912-37-01 Phase II 1 country Fondazione Santobono Pausilipon Onlus
A phase I/II open label study to assess safety, feasibility and efficacy of ex vivo expanded, autologous haematopoietic stem and progenitor … Pending

2024-518972-30-00 Phase I (FiH) 1 country Fondazione Telethon Ets; San Raffaele Hospital
Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell … Pending

2024-520326-11-00 Phase II 1 country Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting

2025-522052-13-00 Phase II/III 9 countries Ospedale Pediatrico Bambino Gesu
ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting

2024-512657-24-00 Phase II/III 12 countries St. Anna Childrens Cancer Research Institute GmbH
Safety and Feasibility of a Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning before Allogeneic Stem Cell Transplantatio… Recruiting

2025-521372-62-00 Phase II 1 country Universitaetsklinikum Tuebingen AöR
Randomized Evaluation of Treosulfan versus Melphalan conditioning fol-lowed by PTCY in Patients with AML and MDS undergoing allogeneic Trans… Recruiting

2023-507879-21-00 Phase II 1 country Technische Universitat Dresden
Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residua… Recruiting

2024-512503-39-00 Phase IV 3 countries Medizinische Hochschule Hannover
Study comparing thymoglobulin to grafalon, two treatments used to prevent graft versus host disease in elderly patients with acute myeloid l… Recruiting

2023-504555-27-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Trial evaluating the safety and efficacy of Venetoclax in addition to a standard conditioning regime in patients with certain forms of leuke… Recruiting

2024-514688-24-00 Phase I/II 1 country Heinrich-Heine-Universitaet Duesseldorf
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Recruiting

2022-500783-35-00 Phase III 6 countries GPOH gGmbH
Study to determine the efficacy of Gemtuzumab Ozogamicin, together with standard chemotherapy, on minimal residual disease levels, in adult … Recruiting

2023-510433-29-00 Phase III 1 country Fondazione Gimema Franco Mandelli Onlus
FIBRAPLO - Haplo-identical transplantation in patients with myleofibrosis Ended

2024-513325-23-00 Phase II 1 country Assistance Publique Hopitaux De Paris

Showing 1–13 of 13 trials

← All drugs A–Z